Dr. Lisa Garcia -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Lisa Garcia, a HIV Medicine physician based in Los Angeles, CA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Lisa Garcia has received $29,628.76 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Lisa Garcia has received a total of $29,628.76 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $29,628.76 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Lisa Garcia's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Consulting Fees$29,628.76Advisory board participation, clinical consulting, and expert opinion services

The largest payment category for Dr. Lisa Garcia is Consulting Fees, accounting for 100% ($29,628.76) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Lisa Garcia. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Gilead Sciences$29,628.761

Dr. Lisa Garcia has a financial relationship with Gilead Sciences, receiving $29,628.76 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Lisa Garcia's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Lisa Garcia has received $29.6K across 1 pharmaceutical payments as a HIV Medicine physician in Los Angeles, CA. Top paying companies include Gilead Sciences ($29.6K). Dr. Garcia received a single payment of $29,629 in 2025. This payment was from Gilead Sciences, representing 100% of her reported pharma payments. The payment was categorized as consulting fees.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Lisa Garcia is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should be aware that a doctor's participation in consulting with pharmaceutical companies is a common practice, often related to research, education, or advisory services. This single payment represents a specific engagement and may not reflect the entirety of their professional activities Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Lisa Garcia Compares to Other HIV Medicine Physicians

For HIV Medicine specialists, payment profiles can vary, but a single large consulting payment from a major pharmaceutical company like Gilead Sciences is not uncommon for research or advisory roles.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Lisa Garcia in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Gilead Sciences$29,628.76consultingN/A2025-03-05Not Assessed

Frequently Asked Questions About Dr. Lisa Garcia's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Lisa Garcia received?

Lisa Garcia has received a total of $29.6K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Lisa Garcia taking too much pharma money?

Lisa Garcia has received $29.6K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (HIV Medicine), the types of payments, and how they compare to peers. The largest payment category is consulting ($29.6K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Lisa Garcia?

The top pharmaceutical companies paying Lisa Garcia are: Gilead Sciences ($29.6K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Lisa Garcia receive?

Lisa Garcia's payments by type: consulting: $29.6K. Consulting fees suggest active advisory roles with pharmaceutical companies.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Lisa Garcia's payments compare to other HIV Medicine doctors?

To compare, look at the total amount ($29.6K), number of payments (1), and the types of payments received. HIV Medicine physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Lisa Garcia's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1780705483). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Lisa Garcia's pharma payment profile?

A single, substantial payment suggests a focused engagement rather than multiple, smaller interactions. Lisa Garcia has received $29.6K in total pharma payments.

How does Lisa Garcia compare to peers in HIV Medicine?

For HIV Medicine specialists, payment profiles can vary, but a single large consulting payment from a major pharmaceutical company like Gilead Sciences is not uncommon for research or advisory roles.

Are Lisa Garcia's pharma relationships typical for HIV Medicine?

The entire payment profile is concentrated with one company, Gilead Sciences.

What should patients of Lisa Garcia know about these payments?

Consumers should be aware that a doctor's participation in consulting with pharmaceutical companies is a common practice, often related to research, education, or advisory services. This single payment represents a specific engagement and may not reflect the entirety of their professional activities

What patterns are visible in Lisa Garcia's payment history?

The payment occurred in the future year of 2025, which may indicate pre-payments or data lag.

Understanding This Doctor Payment Report

This transparency report for Dr. Lisa Garcia is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Lisa Garcia's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Lisa Garcia and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.